Terminal B cell development as seen in different human myelomas and related disorders

T-Cell Membrane CD45RA (2H4) and CD45RO (UCHL1) Determinants: II, Aberrant HLA-ABC Expression by CD45RA and CD45RO Cell Subpopulations of Mature CD4(+) T-Cell Leukaemias.

Leukemia & lymphoma·2016

T-Cell Membrane CD45RA (2H4) and CD45RO (UCHL1) Determinants: I, Diverse Patterns of Expression in Mature (Post-Thymic) T-Cell Proliferations.

Leukemia & lymphoma·2016

Yorkshire Case Control Study of Leukaemias and Lymphomas Parallel Multivariate Analyses of Seven Disease Categories.

Leukemia & lymphoma·2016

The Bag-1 inhibitor, Thio-2, reverses an atypical 3D morphology driven by Bag-1L overexpression in a MCF-10A model of ductal carcinoma in situ.

Oncogenesis·2016

'Supernatural' killer cells.

Immunology today·2014

The cytochemistry of human lymphoreticular subpopulations.

Immunology today·2014

Peripheral T-Cell Transitions Following Proton Pump Inhibitor Therapy in Eosinophilic Esophagitis.

Clinical and experimental immunology·2026

Severity-associated changes in ICOS, CD27, CD127 and CLA expression and expansion of virus-specific T Cells in acute dengue.

Clinical and experimental immunology·2026

Tim-3 Upregulation in Monocyte Subsets as a Distinctive Immune Feature and Early Diagnostic Indicator in Systemic Lupus Erythematosus.

Clinical and experimental immunology·2026

Macrophages in tumors with downregulated MHC-I expression: emerging therapeutic opportunities and translational challenges.

Clinical and experimental immunology·2026

Stage-dependent CD40 signalling defines a shift between protective and suppressive immunity in visceral leishmaniasis.

Clinical and experimental immunology·2026

Post-translational modifications in extracellular microvesicles from plasma of rheumatoid arthritis patients following anti-TNFα therapy.

Clinical and experimental immunology·2026

Anakinra Prophylaxis for Recurrent Severe ICANS Associated With Tarlatamab in Small Cell Lung Cancer: Case Report.

JTO clinical and research reports·2026

Prognostic value of CD103+ tumor-infiltrating lymphocytes in bladder cancer: A systematic review and meta-analysis.

Urologic oncology·2026

Immunotherapy for Glioma: A compartmental framework for resistance and rational combination design.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026

B-cells in breast cancer: current insights and challenges.

Frontiers in oncology·2026

Tumor immunosenescence drives breast cancer progression and therapeutic resistance: mechanisms and emerging interventions.

Frontiers in oncology·2026

The heterogeneous and dynamic immune-tumor interface in breast cancer.

Frontiers in oncology·2026

Related Experiment Videos

Terminal B cell development as seen in different human myelomas and related disorders

Related Concept Videos

T-Cell Membrane CD45RA (2H4) and CD45RO (UCHL1) Determinants: II, Aberrant HLA-ABC Expression by CD45RA and CD45RO Cell Subpopulations of Mature CD4(+) T-Cell Leukaemias.

T-Cell Membrane CD45RA (2H4) and CD45RO (UCHL1) Determinants: I, Diverse Patterns of Expression in Mature (Post-Thymic) T-Cell Proliferations.

Yorkshire Case Control Study of Leukaemias and Lymphomas Parallel Multivariate Analyses of Seven Disease Categories.

The Bag-1 inhibitor, Thio-2, reverses an atypical 3D morphology driven by Bag-1L overexpression in a MCF-10A model of ductal carcinoma in situ.

'Supernatural' killer cells.

The cytochemistry of human lymphoreticular subpopulations.

Peripheral T-Cell Transitions Following Proton Pump Inhibitor Therapy in Eosinophilic Esophagitis.

Severity-associated changes in ICOS, CD27, CD127 and CLA expression and expansion of virus-specific T Cells in acute dengue.

Tim-3 Upregulation in Monocyte Subsets as a Distinctive Immune Feature and Early Diagnostic Indicator in Systemic Lupus Erythematosus.

Macrophages in tumors with downregulated MHC-I expression: emerging therapeutic opportunities and translational challenges.

Stage-dependent CD40 signalling defines a shift between protective and suppressive immunity in visceral leishmaniasis.

Post-translational modifications in extracellular microvesicles from plasma of rheumatoid arthritis patients following anti-TNFα therapy.

Anakinra Prophylaxis for Recurrent Severe ICANS Associated With Tarlatamab in Small Cell Lung Cancer: Case Report.

Prognostic value of CD103+ tumor-infiltrating lymphocytes in bladder cancer: A systematic review and meta-analysis.

Immunotherapy for Glioma: A compartmental framework for resistance and rational combination design.

B-cells in breast cancer: current insights and challenges.

Tumor immunosenescence drives breast cancer progression and therapeutic resistance: mechanisms and emerging interventions.

The heterogeneous and dynamic immune-tumor interface in breast cancer.

Related Experiment Videos

Terminal B cell development as seen in different human myelomas and related disorders

Related Concept Videos

Related Articles